Cape Ann Savings Bank’s Bristol-Myers Squibb BMY Stock Holding History

Cape Ann Savings Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,174	Closed	-$247K	–	89
2021 Q3	$247K	Hold	4,174	–	–	0.16%	81
2021 Q2	$279K	Hold	4,174	–	–	0.18%	82
2021 Q1	$264K	Buy	+4,174	New	+$260K	0.19%	77
2020 Q2	$245K	Buy	+4,174	New	+$250K	0.21%	74

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cape Ann Savings Bank's BMY Position: Q4 2021 in Review

Cape Ann Savings Bank sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 4,174 shares — an estimated $247K sold.

Cape Ann Savings Bank first reported a position in BMY in Q2 2020 and held it in 4 quarters. The position peaked at $279K in Q2 2021. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Cape Ann Savings Bank reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
Cape Ann Savings Bank sold 4,174 Bristol-Myers Squibb shares in Q4 2021, an estimated $247K.
Cape Ann Savings Bank first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 4 quarters.
Cape Ann Savings Bank's Bristol-Myers Squibb position peaked at $279K in Q2 2021.
2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Cape Ann Savings Bank's 13F filing for Q4 2021, filed 16 Feb 2022.